Literature DB >> 15574470

Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.

Mark A Toleman1, Doug Biedenbach, David M C Bennett, Ronald N Jones, Timothy R Walsh.   

Abstract

OBJECTIVES: As part of the SENTRY Antimicrobial Surveillance Programme, 383 non-replicative randomly collected Pseudomonas aeruginosa isolates were collected during 1999-2002. These strains originated from three geographically distinct hospitals within Italy: Genoa (Northern Italy); Rome and Catania (Sicily), and were further studied to identify the prevalence of metallo-beta-lactamase (MbetaL) alleles across Italy and to determine their genetic details.
METHODS: Multidrug-resistant (MDR) strains were identified by MIC analysis followed by genotyping and PCR-based strategies.
RESULTS: Initial MIC analysis identified 31 MDR isolates that displayed an Etest MbetaL-positive phenotype. Of these, 25 produced either the MbetaL VIM-1 or IMP-13 as detected by PCR and sequencing. VIM-1-producing isolates were found at all sites, whereas IMP-13-producing isolates were only found in Rome. MbetaL-producing isolates were found at all Italian SENTRY sites and together amounted to 6.5% of all P. aeruginosa isolates. Genetic analysis indicated that many strains contained multiple integrons and identified two novel MbetaL integrons, one from the site in Genoa and one from Sicily. Integrons identical in structure and sequence to In70, the first identified and characterized bla(VIM)-containing integron from Verona, were found in isolates with distinct ribotypes at the Roman and Sicilian sites indicating that this integron has recently disseminated across Italy. All 25 MbetaL-producing isolates were genetically linked in that all isolates contained Tn5051 sequences and all harboured the insertion sequence IsPa7 which may be involved in the mobilization of these resistance alleles.
CONCLUSIONS: Taken together, these results indicate that Italy has a nationwide problem of MDR P. aeruginosa produced by mobile MbetaL genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574470     DOI: 10.1093/jac/dkh512

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.

Authors:  Allaaeddin El Salabi; Pardha Saradhi Borra; Mark A Toleman; Ørjan Samuelsen; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Authors:  Gisela Santella; Simona Pollini; Jean-Denis Docquier; Ana Irina Mereuta; Gabriel Gutkind; Gian Maria Rossolini; Marcela Radice
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

3.  Purification and biochemical characterization of IMP-13 metallo-beta-lactamase.

Authors:  Gisela Santella; Jean-Denis Docquier; Gabriel Gutkind; Gian Maria Rossolini; Marcela Radice
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

4.  Diverse mobilized class 1 integrons are common in the chromosomes of pathogenic Pseudomonas aeruginosa clinical isolates.

Authors:  Elena Martinez; Carolina Marquez; Ana Ingold; John Merlino; Steven P Djordjevic; H W Stokes; Piklu Roy Chowdhury
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

5.  Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae.

Authors:  Gulcin G Gacar; Kenan Midilli; Fetiye Kolayli; Kivanc Ergen; Sibel Gundes; Salih Hosoglu; Aynur Karadenizli; Haluk Vahaboglu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.

Authors:  Sonia Ktari; Guillaume Arlet; Basma Mnif; Valérie Gautier; Fouzia Mahjoubi; Mounir Ben Jmeaa; Mounir Bouaziz; Adnane Hammami
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

7.  Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis.

Authors:  Rodrigo E Mendes; Katia A Kiyota; Jussimara Monteiro; Mariana Castanheira; Soraya S Andrade; Ana C Gales; Antonio C C Pignatari; Sergio Tufik
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

8.  First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.

Authors:  Catherine Neuwirth; Eliane Siebor; Frederic Robin; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

9.  Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Marta Tato; Teresa M Coque; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

10.  Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.